Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CCL25 belongs to the subfamily of small cytokine CC genes. Additionally we are shipping CCL25 Kits (47) and CCL25 Proteins (42) and many more products for this protein.
Showing 10 out of 112 products:
Human Polyclonal CCL25 Primary Antibody for EIA, WB - ABIN955137
Schuurhof, Bont, Siezen, Hodemaekers, van Houwelingen, Kimman, Hoebee, Kimpen, Janssen: Interleukin-9 polymorphism in infants with respiratory syncytial virus infection: an opposite effect in boys and girls. in Pediatric pulmonology 2010
Show all 2 references for 955137
Human Polyclonal CCL25 Primary Antibody for Func, IHC (p) - ABIN450313
Egan, Sodhi, Good, Lin, Jia, Yamaguchi, Lu, Ma, Branca, Weyandt, Fulton, Niño, Prindle, Ozolek, Hackam: Toll-like receptor 4-mediated lymphocyte influx induces neonatal necrotizing enterocolitis. in The Journal of clinical investigation 2016
TECK was shown to be expressed by osteoblasts, and its receptor, CCR9 (show CCR9 Antibodies), by osteoclast precursors. TECK increased P. gingivalis LPS (show IRF6 Antibodies)-induced osteoclast numbers in an in vitro osteoclast formation assay using osteoclast precursors. T
that CCL25/CCR9 (show CCR9 Antibodies) signal may provide cancer cells with chemotactic abilities through influencing several epithelial-mesenchymal transitionmarkers
CCR9 (show CCR9 Antibodies)/CCL25 interactions are not only involved in colitis pathogenesis but also correlate with colonic inflammatory burden; further supporting the existence of overlapping mucosal lymphocyte recruitment pathways between the inflamed colon and liver.
Studies indicate important roles played by chemokine ligand 25 (CCL25)/chemokine receptor (show CCR1 Antibodies) 9 (CCR9 (show CCR9 Antibodies)) in tumorigenesis, tumor chemoresistance and metastasis.
CCL25 mRNA and protein levels were significantly increased in the nasopharyngeal carcinoma group compared with the control group.
CCR9 (show CCR9 Antibodies)-CCL25 interaction promoted proliferation and suppressed apoptosis of non-small cell lung cancer cells by activating the PI3K (show PIK3CA Antibodies)/Akt (show AKT1 Antibodies) pathway.
High CCL25 expression is associated with the pathogenesis of ulcerative colitis.
Expression of CCR9 (show CCR9 Antibodies) and CCL25, the only natural ligand of CCR9 (show CCR9 Antibodies), was significantly higher (p<0.0001) in NSCLC tissues and serum respectively, compared to their respective controls.
TECK derived from endometrial stromal cell and macrophages upregulates the number and function of Tregs in the ectopic milieu.
CCL25 is an antimicrobial protein with bacteriocidal activity against E. coli and S. aureus.
CCR9 (show CCR9 Antibodies) and CCL25 expressions are induced in the early stages of airway inflammation and they have an important role modulating eosinophils and lymphocytes recruitment at the first stages of inflammatory process
TECK was shown to be expressed by osteoblasts, and its receptor, CCR9 (show CCR9 Antibodies), by osteoclast precursors. TECK increased P. gingivalis LPS (show TLR4 Antibodies)-induced osteoclast numbers in an in vitro osteoclast formation assay using osteoclast precursors. T
CCR9 (show CCR9 Antibodies)/CCL25 is involved in acute skin transplantation rejection and anti-CCL25 strategies might be useful in preventing acute rejection.
Accumulated CD11b (show ITGAM Antibodies)(+) macrophages are critical for activating hepatic stellate cells through the CCR9 (show CCR9 Antibodies)/CCL25 axis and therefore promote liver fibrosis.
The results revealed that during an allergic reaction, CCL25 drives IL-17 (show IL17A Antibodies) gammadelta T-cell mobilization to inflamed tissue via alpha4beta7 integrin and modulates IL-17 (show IL17A Antibodies) levels.
CCL25/CCR9 (show CCR9 Antibodies) interactions regulate inflammatory immune responses in the large intestinal mucosa by balancing different subsets of dendritic cells.
Characterization of mouse CCX-CKR (show CCRL1 Antibodies), a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC (show CCL21A Antibodies)/mCCL21 and MIP (show MIP Antibodies)-3beta/mCCL19: comparison to human CCX-CKR (show CCRL1 Antibodies). (CCX-CKR (show CCRL1 Antibodies))
in vivo neutralization of the CCR9 (show CCR9 Antibodies) ligand, CCL25, reduced the ability of activated CCR9 (show CCR9 Antibodies)(+) CD8alphabeta(+) lymphocytes cells to populate the small-intestinal epithelium
role of CCL25 in the generation of the small-intestinal CD8alpha alpha(+)CD3 (show CD3E Antibodies)(+) intraepithelial lymphocyte compartment
chemokine (C-C motif) ligand 25 may thus play an important role in the adherence of mucosal lymphocytes to the microvessels of the small intestine but not the colon under uninflamed as well as inflamed conditions
This gene belongs to the subfamily of small cytokine CC genes. Cytokines are a family of secreted proteins involved in immunoregulatory and inflammatory processes. The CC cytokines are proteins characterized by two adjacent cysteines. The cytokine encoded by this gene displays chemotactic activity for dendritic cells, thymocytes, and activated macrophages but is inactive on peripheral blood lymphocytes and neutrophils. The product of this gene binds to chemokine receptor CCR9. Alternative splicing results in multiple transcript variants.
C-C motif chemokine 25
, chemokine CCL25/TECK
, small inducible cytokine A25
, chemokine (C-C motif) ligand 25
, Ck beta-15
, chemokine TECK
, small inducible cytokine subfamily A (Cys-Cys), member 25
, small-inducible cytokine A25
, thymus expressed chemokine
, thymus-expressed chemokine
, small inducible chemokine 25
, CC chemokine ligand 25
, chemokine ligand 25